The association of histopathologic features after neoadjuvant chemo-immunotherapy with clinical outcome: Sub-analyses from the randomized double-blinded, placebo-controlled, Phase III IMagyn050/GOG3015/ENGOT-ov39 study

Authors: Bookman, Michael A | Gynecologic Oncology | March 29, 2024 | PubMed abstract

Explore all publications

Back To Top